TKM-PLK1 / Arbutus  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TKM-PLK1 / Arbutus
NCT01262235: A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Checkmark Interim data from P1 trial
Feb 2013 - Feb 2013: Interim data from P1 trial
Completed
1/2
68
US
TKM-080301, PLK1 SNALP, TKM-PLK1
Arbutus Biopharma Corporation
Cancer, Neuroendocrine Tumors, NET, Adrenocortical Carcinoma, ACC
07/15
08/15
NCT02191878: Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma

Completed
1/2
43
Canada, US, RoW
TKM-080301, PLK1-HCC
Arbutus Biopharma Corporation
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult, Liver Cell Carcinoma, Adult
05/16
07/16

Download Options